Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 885 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · derivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 885 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Tax withholdingCommon Stock | 234 | $246.27 | $57,627.18 |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,651 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Exercise / conversionCommon Stock | 885 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Exercise / conversionRestricted Stock Unit · Derivative | 354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · derivative · entry 6 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,390 Underlying: Common Stock · 354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Tax withholdingCommon Stock | 94 | $246.27 | $23,149.38 |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · nonDerivative · entry 4 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,443 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Exercise / conversionCommon Stock | 354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · nonDerivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Exercise / conversionRestricted Stock Unit · Derivative | 112 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · derivative · entry 9 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,441 Underlying: Common Stock · 112 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F6 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Exercise / conversionRestricted Stock Unit · Derivative | 517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · derivative · entry 8 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,553 Underlying: Common Stock · 517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F6 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 33 | $246.27 | $8,126.91 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 6 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,998.6573 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Exercise / conversionCommon Stock | 112 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 5 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,031.6573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 149 | $246.27 | $36,694.23 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 4 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,919.6573 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Exercise / conversionCommon Stock | 517 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 3 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,068.6573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionRestricted Stock Unit · Derivative | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · derivative · entry 9 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,046 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionRestricted Stock Unit · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · derivative · entry 8 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,113 Underlying: Common Stock · 224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Tax withholdingCommon Stock | 22 | $246.27 | $5,417.94 |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 6 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionCommon Stock | 67 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 5 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Tax withholdingCommon Stock | 85 | $246.27 | $20,932.95 |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 4 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 685 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:18 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionCommon Stock | 224 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 3 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:17 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
Exercise / conversionRestricted Stock Unit · Derivative | 149 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003718 · form4.xml · derivative · entry 6 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,753 Underlying: Common Stock · 149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal installments beginning on February 7, 2025. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal installments beginning on February 7, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:17 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
Tax withholdingCommon Stock | 51 | $246.27 | $12,559.77 |
DisclosureSEC source: 0001127602-25-003718 · form4.xml · nonDerivative · entry 4 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,882.253 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:17 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
Exercise / conversionCommon Stock | 149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003718 · form4.xml · nonDerivative · entry 3 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,933.253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:16 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003717 · form4.xml · derivative · entry 6 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 870 Underlying: Common Stock · 224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:16 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 68 | $246.27 | $16,746.36 |
DisclosureSEC source: 0001127602-25-003717 · form4.xml · nonDerivative · entry 4 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,624.5 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:16 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 224 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003717 · form4.xml · nonDerivative · entry 3 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,692.5 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionRestricted Stock Unit · Derivative | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · derivative · entry 9 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,641 Underlying: Common Stock · 164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionRestricted Stock Unit · Derivative | 517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · derivative · entry 8 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,805 Underlying: Common Stock · 517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Tax withholdingCommon Stock | 47 | $246.27 | $11,574.69 |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 6 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,057.1426 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionCommon Stock | 164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 5 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,104.1426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Tax withholdingCommon Stock | 146 | $246.27 | $35,955.42 |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 4 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,940.1426 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:15 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionCommon Stock | 517 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 3 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,086.1426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:13 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003715 · form4.xml · derivative · entry 6 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524 Underlying: Common Stock · 134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:13 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 46 | $246.27 | $11,328.42 |
DisclosureSEC source: 0001127602-25-003715 · form4.xml · nonDerivative · entry 4 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,262.2194 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:13 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 134 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003715 · form4.xml · nonDerivative · entry 3 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,308.2194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:12 UTC |
Schechter Adam HDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003714 · form4.xml · derivative · entry 6 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,132 Underlying: Common Stock · 3,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Common Inc. Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:12 UTC |
Schechter Adam HDirector · President & CEO
|
Tax withholdingCommon Stock | 1,345 | $246.27 | $331,233.15 |
DisclosureSEC source: 0001127602-25-003714 · form4.xml · nonDerivative · entry 4 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,566 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:12 UTC |
Schechter Adam HDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003714 · form4.xml · nonDerivative · entry 3 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Common Inc. Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:11 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003713 · form4.xml · derivative · entry 6 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450 Underlying: Common Stock · 354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F6 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:11 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 94 | $246.27 | $23,149.38 |
DisclosureSEC source: 0001127602-25-003713 · form4.xml · nonDerivative · entry 4 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,247.5397 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:11 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003713 · form4.xml · nonDerivative · entry 3 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,341.5397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC |
GRAHAM ANITA ZEVP, CHRO
|
Exercise / conversionRestricted Stock Unit · Derivative | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · derivative · entry 6 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,021 Underlying: Common Stock · 369 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC |
GRAHAM ANITA ZEVP, CHRO
|
Tax withholdingCommon Stock | 119 | $246.27 | $29,306.13 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 4 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC |
GRAHAM ANITA ZEVP, CHRO
|
Exercise / conversionCommon Stock | 369 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 3 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 966 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,511 Underlying: Common Stock · 966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Tax withholdingCommon Stock | 255 | $247.74 | $63,173.70 |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:14 UTC |
EISENBERG GLENN AExecutive Vice President
|
Exercise / conversionCommon Stock | 966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Exercise / conversionRestricted Stock Unit · Derivative | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · derivative · entry 5 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,744 Underlying: Common Stock · 356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Tax withholdingCommon Stock | 94 | $247.74 | $23,287.56 |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,183 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 15:12 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Exercise / conversionCommon Stock | 356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003722 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Exercise / conversionRestricted Stock Unit · Derivative | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · derivative · entry 7 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,070 Underlying: Common Stock · 670 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:20 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 212 | $247.74 | $52,520.88 |
DisclosureSEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 2 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,551.6573 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.